RNAi medicine for the brain: progresses and challenges
Open Access
- 31 March 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 20 (R1) , R21-R27
Abstract
RNAi interference (RNAi) is a powerful gene silencing technology that has immense potential for treating a vast array of human ailments, for which suppressing disease-associated genes may provide clinical benefit. Here, we review the development of RNAi as a therapeutic modality for neurodegenerative diseases affecting the central nervous system (CNS). We overview promising preclinical data for the application of RNAi in the CNS and discuss key challenges (e.g. delivery and specificity) that remain as these approaches transition to the clinic.Keywords
This publication has 88 references indexed in Scilit:
- The widespread regulation of microRNA biogenesis, function and decayNature Reviews Genetics, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Allele-specific RNAi Mitigates Phenotypic Progression in a Transgenic Model of Alzheimer's DiseaseMolecular Therapy, 2009
- Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease MiceMolecular Therapy, 2009
- A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interferenceExperimental Neurology, 2009
- Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAsRNA, 2008
- Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficitsProceedings of the National Academy of Sciences, 2007
- Clinico-pathological rescue of a model mouse of Huntington's disease by siRNANeuroscience Research, 2005
- Role of MicroRNAs in Plant and Animal DevelopmentScience, 2003
- siRNA-mediated gene silencing in vitro and in vivoNature Biotechnology, 2002